Researchers sought to collect information on the characteristics of MS-related TN and on the frequency and type of medical/surgical treatments.
Long-term treatment with inotersen is effective for polyneuropathy secondary to hATTR amyloidosis with a promising long-term safety profile.
Several cardiac and kidney biomarkers may be used to identify older adults with peripheral neuropathy.
Metabolic syndrome factors and modifiable lifestyle habits are associated with prevalence of diabetic polyneuropathy and neuropathic pain.
Researchers compared the health-related quality of life in patients with Sjögren syndrome, with and without peripheral neuropathy.
Abnormally rapid corneal nerve fiber loss may indicate increased risk for the development and progression of diabetic distal symmetric polyneuropathy.
Several nonglycemic factors may increase the risk for the development of diabetic peripheral neuropathy among people with type 1 diabetes.
The relative incidence of shingles is lower in adults after exposure to a household contact with chickenpox, but full protection is not achieved.
Peripheral nervous system disease is a component of systemic lupus erythematosus disease activity and has a significant negative impact on health-related quality of life.
A Prescription Drug User Fee Act (PDUFA) target date of July 13, 2020 has been assigned to the application.